Nutrition and Obesity Resource Center

CLINICAL QUIZ: Diabetes Case Questions

A 47-year-old woman with primary hypothyroidism and osteoarthritis of the right knee presented to the clinic for follow-up. She is trying to lose weight in preparation for right knee surgery. The weight loss has plateaued on a low-calorie meal plan. Her exercise is limited by chronic knee pain. She tracks her calories and daily steps. After the discussion about the risks and benefits of weight loss medications, she was started on phentermine/topiramate extended-release daily. She returns three months later and has lost 3% of her body weight since the last visit. On physical examinati

Obesity Case 11

A 63-year-old African American male with a history of obesity, T2DM, CKD3b and recent NSTEMI was referred for cardiometabolic risk optimization.

Medications: atorvastatin 80mg, lisinopril 20mg, aspirin 162mg, metformin 1000mg bid, metoprolol 50mg daily, duloxetine 20mg daily

Diet:

Obesity Case 9

A 27 year-old woman with a history of obesity, polycystic ovary syndrome (PCOS) and primary hypothyroidism is referred to you for recent weight gain. She also has a history of recurrent kidney stones. Despite her best efforts to follow a meal plan as prescribed by a registered dietitian and increasing her physical activity by hiring a personal trainer, she has gained 20 pounds in the 6 months prior to her visit with you. She reports recent trouble with portion control.

View all Diabetes Clinical Cases

CLINICAL PRACTICE GUIDELINES

Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults

The American Association of Clinical Endocrinologists (AACE) and The Obesity Society (TOS) are professional organizations dedicated to improve the lives of patients with endocrine and metabolic disorders.

Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity (2016)

These AACE/ACE evidence-based clinical practice guidelines address key aspects of obesity care: screening, diagnosis, clinical evaluation, treatment options, therapy selection, and treatment goals.

AACE Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2017 Update

Clinical practice guideline (CPG), clinical practice algorithm (CPA), and clinical checklist (CC, collectively CPGAC) development is a high priority of the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE).

View all Guidelines

TREATMENT ALGORITHM

Treatment Algorithm for the Medical Care of Patients With Obesity

Use AACE's step-by-step interactive guide to successfully implement a multifaceted patient care plan with evidence-based obesity treatment strategies.

View all Treatment Algorithms

SLIDE LIBRARY

Integrating Obesity Medicine into Your Practice

Do you want to incorporate obesity medicine into your medical practice but don't know where to start? The disease of obesity is increasing at an alarming rate in the US and worldwide.

View Slides

Obesity: Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Key Points Key Points

Define NAFLD and NASH
Screening and diagnosis of NAFLD and NASH
Progression and presentation of NASH

Download Slides (PDF)

Individualizing Weight Loss Therapy

Help your patients understand Obesity is a disease and it needs to be treated. Obesity is quickly becoming an epidemic in the United States.

DOWNLOAD FILE (PDF)

View all Slide Library

RESOURCE TOOLKITS

AACE Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Off-label use and misuse of testosterone, GH, thyroid hormone, and adrenal supplements have become increasingly prevalent. Many patients seek treatment for common nonspecific symptoms such as fatigue, low energy, poor sleep, weight gain, and lower libido. Unfortunately, some clinics and websites lead people to believe that their symptoms are attributable to a deficiency of a hormone and that treatment with this hormone will eliminate their symptoms.

Office Tools

Drug Information Tools for Patients

View all Resource Toolkits

IN-DEPTH INFORMATION

View all In-depth

Section 1. What Is the Disease of Obesity?

AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity Recommendations

Section 2. Why Do We Treat Obesity?

Obesity prevalence has risen steadily for several decades, and the disease, its complications, and comorbidities place a huge burden on patients and society. Obesity is estimated to add $3,559 annually (adjusted to 2012 dollars) to per-patient medical expenditures as compared to patients who do not have obesity; this includes $1,372 each year for inpatient services, $1,057 for outpatient services, and $1,130 for prescription drugs.

Section 3. How Do We Treat Obesity?

The primary therapeutic goal of obesity management is improvement in adiposity-related complications, not a preset decline in body weight. Lifestyle intervention is a vital component of all weight loss regimens; the choice of whether to implement lifestyle therapy alone or combine it with weight-loss medications or bariatric surgery will depend on the severity of each individual patient’s obesity and related complications.¹

EDUCATIONAL OPPORTUNITIES

Endocrine University Year 1

This program is intended for first year endocrine Fellows-in-Training. Endocrine University® is designed to provide a forum for endocrinology fellows-in-training to enhance their endocrine curriculum, particularly in new technology, which has become essential to the practice of endocrinology.

Endocrine University Year 2: Disease Management for Endocrinology Fellows in Training

Endocrine University Year 2: Disease Management for Endocrinology Fellows in Training will be held in a live, virtual environment on November 13 - 15, 2020.

AACE Innovation in Cardiometabolic Clinical Practice

Save the date for October 2021! You won't want to miss the next annual AACE Innovation in Cardiometabolic Clinical Practice — designed for the care team by the care team.

View all Educational Opportunities

SCIENTIFIC ARTICLES

Endocrine Practice - the Journal for Clinical Endocrinologists

Endocrine Practice, our official journal, keeps you on the leading edge of endocrine patient care.

Immediately Accessible Endocrine Case Studies

Access a wide range of case reports and commentary from noted endocrinology experts.

DPP4 Inhibitor Sitagliptin as a Potential Treatment Options in Metformin-Intolerant Obese Women With Polycystic Ovary Syndrome: A Pilot Randomized Study

Metformin has an established role in the management of polycystic ovary syndrome (PCOS). Some patients cannot tolerate it due to associated gastrointestinal adverse events. The present study evaluated the dipeptidyl peptidase 4 inhibitor sitagliptin as a potential treatment option in metformin-intolerant PCOS.

View all Articles

RECENT NEWS AND UPDATES

March 24, 2020

FDA Releases New Nutrition Facts Label for the First Time in 20 Years

The U.S. Food and Drug Administration has updated the Nutrition Facts label.

August 18, 2020 (Latest Update)

COVID-19 Resources: Telehealth, Updates and More

AACE is closely monitoring developments regarding COVID-19 and working with partner medical societies to provide information and resources to our members. Click to view COVID-19 resources, including more about navigating telehealth services.

March 4, 2020

AACE Joins Forces with Major Scientific Organizations in a Pledge to End Obesity Stigma

Coinciding with World Obesity Day, AACE has joined over 100 medical and scientific organizations across the world in pledging our support for a consensus statement that recognizes unscientific public narratives of obesity as a major cause of weight stigma and calls for strong policies and legislation to prevent weight-based discrimination.

See all the latest

POSITION AND CONSENSUS STATEMENTS

AACE Position Statement on Clinical Nutrition and Health Promotion in Endocrinology 2012

The discipline of clinical nutrition is spread over a diverse array of medical and surgical specialties.

Since its inception, the American Association of Clinical Endocrinologists (AACE) has advocated for the finest in endocrine education and state-of-the-art health-care delivery without regard to race, ethnicity, gender, age, country of origin, economic status, lifestyle, sexual orientation or domestic living arrangements.

Transculturalization Recommendations for Developing Latin American Clinical Practice Algorithms in Endocrinology

Evidence-based medicine has generated many philosophical and pragmatic challenges to clinical care. Chief among these challenges is how to deliver culturally appropriate individualized endocrine care while adhering to evidence-based guidelines and algorithms developed for large heterogeneous populations.

View all Position Statements

AACE would like to thank the following companies for grants supporting the Nutrition and Obesity Resource Center:

Nutrition and Obesity Treatment